Article 22 Dec 2023 Tech Support: FDA's Evolving Regulatory Plan For Drug- And Device-Enabling Software United States Healthcare
Article 16 Nov 2023 CMS Promotes Competition, Transparency, Health Equity And More In The CY2025 Medicare Advantage And Part D Proposed Rule United States Healthcare
Article 20 Oct 2023 FDA's Proposed Rule On LDT Regulation And The Debate Over Agency Deference United States Healthcare
Article 27 Sep 2023 FDA Clarifies Labeling Expectations For Prescription Drug Use-Related Software United States Healthcare
Article 28 Jul 2023 FDA Maintains Focus On "Intended Use" For Software-Enabled Medical Devices United States Healthcare
Article 23 Jun 2023 The Drug Price Negotiation Program Faces Pushback From Private And Public Industry Participants United States Healthcare
Article 10 May 2023 Withdrawal Of Drug Approval Highlights Risk Of Accelerated Approval Pathway United States Healthcare
Article 25 Apr 2023 FDA To Require Demonstration Of Cybersecurity Safeguards For Pre-Market Submissions Of Certain Medical Devices United States Technology
Article 29 Mar 2023 Payor-Led Initiatives To Strengthen Mental Health Resources United States Healthcare